One reason for cognitive problems in schizophrenia & Alzheimer’s

03/2013

New findings support a mathematical model predicting that the slow, steady firing of neurons in the dorsolateral prefrontal cortex that maintains visual representations in working memory relies on a class of NMDA receptors known as NR2B receptors. Blocking these receptors abolished persistent firing among pyramidal Delay cells.

Earlier studies have shown these types of NMDA receptors are often altered in patients with schizophrenia. They also seem to be altered in Alzheimer’s patients. The findings suggest that this may be one cause of cognitive deficits in those with schizophrenia and Alzheimer’s.

Ketamine, an anesthetic often abused as a street drug, also blocked these receptors, explaining at least in part why ketamine abuse can produce schizophrenia-like symptoms.

https://www.futurity.org/health-medicine/brains-sketch-pad-goes-blank-in-schizophrenia/

[3323] Wang, M., Yang Y., Wang C-J., Gamo N. J., Jin L. E., Mazer J. A., et al.
(2013). NMDA Receptors Subserve Persistent Neuronal Firing during Working Memory in Dorsolateral Prefrontal Cortex.
Neuron. 77(4), 736 - 749.

schizophrenia

dorsolateral prefrontal cortex

Related News

Tau protein travels with neuronal signals

Tau protein stabilizes structures that transport supplies from the center of the cell to the extremities, but sometimes some tau is not bound to these microtubules and instead clumps together into

How inflammation and hypoxia damage the brain

A new study shows that a combination of inflammation and hypoxia activates microglia in a way that persistently weakens the connection between neurons,

APP found to also be involved in neurogenesis

A new function has been found for the

Are sleep problems a key factor in Alzheimer’s?

I reported a few months ago on some evidence of a link between disturbed sleep and the development of Alzheimer’s. Now a mouse study adds to this evidence.

Genes, brain size, brain atrophy, and Alzheimer’s risk

Genetic analysis of 9,232 older adults (average age 67; range 56-84) has implicated four genes in how fast your

Alzheimer's protein may impair mental function even in healthy adults

Another study adds to the evidence that changes in the brain that may lead eventually to Alzheimer’s begin many years before Alzheimer’s is diagnosed.

Discovery of more risky genes reveals more about the paths to Alzheimer’s

I commonly refer to ApoE4 as the ‘Alzheimer’s gene’, because it is the main genetic risk factor, tripling the risk for getting Alzheimer's. But it is not the only risky gene.

High iron, copper levels block neuron repair

A new study finds out why curcumin might help protect against dementia, and links two factors associated with Alzheimer’s and Parkinson’s diseases: DNA damage by reactive oxygen species (ROS), and excessive levels of copper and iron in parts of the brain.

Vascular disease underlies cognitive decline in healthy aging

More evidence that vascular disease plays a crucial role in age-related cognitive impairment and Alzheimer’s comes from data from participants in the Alzheimer's Disease Neuroimaging Initiative.

How the Alzheimer’s gene works; implications for treatment

Carriers of the so-called ‘Alzheimer’s gene’ (apoE4) comprise 65% of all Alzheimer's cases. A new study helps us understand why that’s true.

Pages